Insider Sellers Might Regret Selling Alector Shares at a Lower Price Than Current Market Value
Despite the fact that Alector, Inc.'s (NASDAQ:ALEC) value has dropped 12% in the last week insiders who sold US$709k worth of stock in the past 12 months have had less success.
Simply Wall StApr 17 07:12 ET
The Past Five Years for Alector (NASDAQ:ALEC) Investors Has Not Been Profitable
Yahoo FinanceApr 11 10:26 ET
Alector Inc Announces Board Retirement and New Members
TipRanksMar 21 16:12 ET
Alector's Clinical Progress and Financial Health Anchor Buy Recommendation
TipRanksMar 7 00:06 ET
Alector(ALEC.US) Officer Sells US$70,386.77 in Common Stocks
$Alector(ALEC.US)$ Officer Kenkare-Mitra Sara sold 10,169 shares of Common Stocks on Mar 4, 2024 at an average price of $6.9217 for a total value of $70,386.77.Source: Announcement What is statement o
moomoo NewsMar 5 18:42 ET
Alector(ALEC.US) Officer Sells US$39,561.58 in Common Stocks
$Alector(ALEC.US)$ Officer GRASSO MARC sold 5,716 shares of Common Stocks on Mar 4, 2024 at an average price of $6.9212 for a total value of $39,561.58.Source: Announcement What is statement of change
moomoo NewsMar 5 18:42 ET
Alector(ALEC.US) Officer Sells US$41,553.92 in Common Stocks
$Alector(ALEC.US)$ Officer Romano Gary sold 6,001 shares of Common Stocks on Mar 4, 2024 at an average price of $6.9245 for a total value of $41,553.92.Source: Announcement What is statement of change
moomoo NewsMar 5 18:42 ET
Alector(ALEC.US) Officer Sells US$130.39K in Common Stocks
$Alector(ALEC.US)$ Officer Rosenthal Arnon sold 18,837 shares of Common Stocks on Mar 4, 2024 at an average price of $6.9218 for a total value of $130.39K.Source: Announcement What is statement of cha
moomoo NewsMar 5 18:42 ET
Analysts Offer Insights on Healthcare Companies: DocGo (DCGO), Revance Therapeutics (RVNC) and Alector (ALEC)
TipRanksFeb 29 06:40 ET
Express News | HC Wainwright & Co. Reiterates Buy on Alector, Maintains $41 Price Target
Moomoo 24/7Feb 28 12:11 ET
Alector, Inc. (NASDAQ:ALEC) Q4 2023 Earnings Call Transcript
Yahoo FinanceFeb 28 10:13 ET
Optimistic Buy Rating for Alector's AL002 Based on Promising Alzheimer's Disease Trial Biomarkers and TREM2 Signaling Efficacy
TipRanksFeb 28 07:38 ET
Alector (NASDAQ:ALEC) Adds US$76m to Market Cap in the Past 7 Days, Though Investors From Five Years Ago Are Still Down 64%
While not a mind-blowing move, it is good to see that the Alector, Inc. (NASDAQ:ALEC) share price has gained 29% in the last three months. But that is little comfort to those holding over the last
Simply Wall StFeb 28 07:03 ET
Alector to Participate in Upcoming Healthcare Conferences
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (NASDAQ:ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that management will participate in the
GlobeNewswireFeb 28 07:00 ET
Alector: Cautious Hold Rating Ahead of Key Clinical Trial Milestones and Financial Assessment
TipRanksFeb 28 05:37 ET
Earnings Call Summary | Alector(ALEC.US) Q4 2023 Earnings Conference
The following is a summary of the Alector, Inc. (ALEC) Q4 2023 Earnings Call Transcript:Financial Performance:Alector ended Q4 2023 with $548.9 million. Raised $75 million from a financing offer in Ja
moomoo AIFeb 28 04:10 ET · Conference Call
Alector (ALEC) Receives a Buy From Barclays
TipRanksFeb 28 03:37 ET
TD Cowen Sticks to Their Buy Rating for Alector (ALEC)
TipRanksFeb 27 19:05 ET
Express News | Alector Sees 2024 Collaboration Revenue $60M-$70M, Total R&D Expenses $210M-$230M
Moomoo 24/7Feb 27 17:04 ET
Recap: Alector Q4 Earnings
Alector (NASDAQ:ALEC) reported its Q4 earnings results on Tuesday, February 27, 2024 at 04:05 PM.Here's what investors need to know about the announcement.EarningsAlector beat estimated earnings by 36
BenzingaFeb 27 16:50 ET
No Data
No Data